Enzo Biochem INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
SCHEDULE: Beryl Capital Exits Enzo Biochem Stake
Beryl Capital Management and its affiliates have reported a 0% beneficial ownership in Enzo Biochem Inc., indicating a full divestment or reduction below reporting thresholds.
Beryl Capital Management and its affiliates have disclosed a significant beneficial ownership stake of 9.7% in Enzo Biochem Inc., totaling 5,069,789 shares of common stock.